Thomas Schinecker

Speaker at the St. Gallen Symposium

Dr Thomas Schinecker has been Chief Executive Officer of the Roche Group since March 2023 and a member of the Corporate Executive Committee since 2019. Prior to assuming his current role, he served as interim CEO of the Pharmaceuticals Division in early 2023. For two years, he led Roche Diagnostics' largest business unit, including research and development, before taking over as CEO of the Diagnostics Division (2019–2022). Dr Schinecker joined Roche in 2003 as part of a management development programme. Over the course of his career at the company, he has held leadership positions across six countries and three continents. Before taking on more senior leadership roles, he served as Head of Marketing and Sales in Austria, Lifecycle Leader for Diagnostics' Sequencing Solutions in the United States, and General Manager of Roche Diagnostics in both Sweden and Germany. Alongside his work at Roche, Dr Schinecker serves as a member of the Innovation Board of Labor Berlin (Charité and Vivantes), Chair of the Biopharmaceutical CEOs Roundtable (BCR), and President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), both since 2025. He was also elected to the Board of Directors of Chugai Pharmaceutical in Japan in 2025. Born in Germany, Dr Schinecker holds both German and Austrian citizenship and grew up in Singapore. He studied genetics in Salzburg, Austria, and earned a PhD in molecular biology from New York University in 2003.